DCLK1 as a Promising Marker for Radioresistance in Colorectal Cancer

被引:3
|
作者
Mohammadi, Chiman [1 ]
Najafi, Rezvan [1 ]
机构
[1] Hamadan Univ Med Sci, Res Ctr Mol Med, Hamadan, Hamadan, Iran
关键词
D O I
10.1007/s12029-019-00292-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:714 / 715
页数:2
相关论文
共 50 条
  • [11] DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma
    Lorenzo, Nevi
    Sabina, Di Matteo
    Guido, Carpino
    Grazia, Zizzari Ilaria
    Samira, Safarikia
    Valeria, Ambmsino
    Daniele, Costantini
    Diletta, Overi
    Antonella, Giancotti
    Marco, Monti
    Daniela, Bosco
    Valerio, De Peppo
    Andrea, Oddi
    Maria, De Rose Agostino
    Fabio, Melandro
    Consiglia, Bragazzi Maria
    Jessica, Faccioli
    Sara, Massironi
    Luca, Grazi Gian
    Benedetti, Panici Pierluigi
    Bartomeo, Berloco Paquale
    Felice, Giuliante
    Vincenzo, Cardinale
    Pietro, Invernizzi
    Giuseppina, Caretti
    Eugenio, Gaudio
    Domenico, Alvaro
    HEPATOLOGY, 2021, 73 (01) : 144 - 159
  • [12] The DCLK1 Tumor Stem Cell Marker Is a Central Regulatory Component of the Epithelial-Mesenchymal Transition Program in Colorectal Cancer
    May, Randal
    Weygant, Nathaniel
    Berry, William L.
    Qu, Dongfeng
    Chandrakesan, Parthasarathy
    Sureban, Sripathi M.
    Houchen, Courtney W.
    GASTROENTEROLOGY, 2015, 148 (04) : S573 - S573
  • [13] DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner
    Sepideh Razi
    Asieh Sadeghi
    Zeynab Asadi-Lari
    Kevin J. Tam
    Elham Kalantari
    Zahra Madjd
    Clinical and Experimental Medicine, 2021, 21 : 139 - 147
  • [14] DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent manner
    Razi, Sepideh
    Sadeghi, Asieh
    Asadi-Lari, Zeynab
    Tam, Kevin J.
    Kalantari, Elham
    Madjd, Zahra
    CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (01) : 139 - 147
  • [15] Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients
    Mirzaei, Alireza
    Tavoosidana, Gholamreza
    Modarressi, Mohammad Hossein
    Rad, Afshin Abdi
    Fazeli, Mohammad Sadegh
    Shirkoohi, Reza
    Tavakoli-Yaraki, Masoumeh
    Madjd, Zahra
    TUMOR BIOLOGY, 2015, 36 (06) : 4801 - 4810
  • [16] The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer
    Gzil, Arkadiusz
    Szylberg, Lukasz
    Jaworski, Damian
    Dominiak, Joanna
    Zarebska, Izabela
    Grzanka, Dariusz
    ANTICANCER RESEARCH, 2019, 39 (06) : 2689 - 2697
  • [17] Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness
    Park, So-Yeon
    Kim, Ji-Young
    Choi, Jang-Hyun
    Kim, Jee-Heun
    Lee, Choong-Jae
    Singh, Pomila
    Sarkar, Shubhashish
    Baek, Jeong-Heum
    Nam, Jeong-Seok
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1415 - 1429
  • [18] High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors
    Ikezono, Yu
    Koga, Hironori
    Abe, Mitsuhiko
    Akiba, Jun
    Kawahara, Akihiko
    Yoshida, Takafumi
    Nakamura, Toru
    Iwamoto, Hideki
    Yano, Hirohisa
    Kage, Masayoshi
    Sata, Michio
    Tsuruta, Osamu
    Torimura, Takuji
    ONCOLOGY LETTERS, 2015, 10 (04) : 2015 - 2020
  • [19] High Tumor DCLK1 Levels at Colorectal Cancer Diagnosis Predict Poor Survival
    Weygant, Nathaniel
    Vega, Kenneth J.
    Houchen, Courtney
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S550 - S551
  • [20] DCLK1 Expression in Colorectal Polyps Increases with the Severity of Dysplasia
    Takiyama, Aki
    Tanaka, Toshiaki
    Kazama, Shinsuke
    Nagata, Hiroshi
    Kawai, Kazushige
    Hata, Keisuke
    Otani, Kensuke
    Nishikawa, Takeshi
    Sasaki, Kazuhito
    Kaneko, Manabu
    Emoto, Shigenobu
    Murono, Koji
    Takiyama, Hirotoshi
    Nozawa, Hiroaki
    IN VIVO, 2018, 32 (02): : 365 - 371